Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Diabetes with Diabetic Chronic Kidney Disease (Diagnosis)”

110 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 110 results

Not applicableNot Yet RecruitingNCT07354958
What this trial is testing

Impact of Diabetes-Related Metabolic Derangements on Clinical Outcomes in Hospitalized Patients With Chronic Kidney Disease

Who this might be right for
Diabetic Chronic Kidney Disease Patients
Sohag University 200
Not applicableStudy completedNCT03344549
What this trial is testing

Effect of the Teleconsultation of Renal Nutrition on Renal Function and Glycemic Control in Patients With DKD

Who this might be right for
Diet ModificationDiabetic Kidney DiseaseChronic Kidney Diseases
Hospital Civil Juan I. Menchaca 53
Not applicableStudy completedNCT04016155
What this trial is testing

Flash Glucose Monitoring in Reduction of Hypoglycaemia in Diabetic Patients with Chronic Kidney Disease

Who this might be right for
Diabetes with Diabetic Chronic Kidney Disease (Diagnosis)
Chinese University of Hong Kong 94
Post-approval studies (Phase 4)Looking for participantsNCT07187713
What this trial is testing

ACE Reno, Pico Cell Matrix and Its Effect on eGFR in Chronic Kidney Diseases

Who this might be right for
Hypertensive NephropathyAuto Immune DisordersChronic Kidney Disease+5 more
Ace Cells Lab Limited 300
Testing effectiveness (Phase 2)Study completedNCT02316821
What this trial is testing

The Phase II Study of Bardoxolone Methyl in Patients With Chronic Kidney Disease and Type 2 Diabetes; TSUBAKI Study

Who this might be right for
Chronic Kidney DiseaseType 2 Diabetes
Kyowa Kirin Co., Ltd. 216
Not applicableStudy completedNCT00364988
What this trial is testing

Pioglitazone and Losartan Provides Additional Renoprotection

Who this might be right for
Type 2 DiabetesDiabetic Nephropathy
Shanghai Jiao Tong University School of Medicine 60
Not applicableUnknownNCT04961931
What this trial is testing

Effect of Empagliflozin on Urinary Excretion of Adenosine and Osteocyte Function in Patients With Chronic Kidney Disease

Who this might be right for
Chronic Kidney Disease stage3
Medical University of Lodz 45
Not applicableStudy completedNCT05631119
What this trial is testing

Biorepository of Biospecimen Samples in Matched Healthy Control Participants and Participants Diagnosed With Diabetic Kidney Disease, Chronic Kidney Disease, or Type 2 Diabetes

Who this might be right for
Diabetic Kidney DiseaseDiabetes Type 2Chronic Kidney Diseases+1 more
Sanguine Biosciences 40
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07325201
What this trial is testing

Reducing Risk of Diabetic Ketoacidosis in Type 1 Diabetes and Kidney Disease Using Continuous Ketone Monitoring

Who this might be right for
Type 1 Diabetes MellitusChronic Kidney Disease (CKD) With Diabetes Mellitus (DM)Chronic Kidney Disease
HealthPartners Institute 80
Post-approval studies (Phase 4)Study completedNCT03226457
What this trial is testing

SGLT2 Inhibition in Combination With Diuretics in Heart Failure

Who this might be right for
Heart FailureType 2 Diabetes Mellitus
University of Dundee 23
Not applicableStudy completedNCT04931030
What this trial is testing

Low Carbohydrate Diet in Diabetic Kidney Disease

Who this might be right for
Type 2 Diabetes MellitusDiabetic Kidney DiseaseObesity
Universiti Teknologi Mara 30
Not applicableLooking for participantsNCT06752577
What this trial is testing

Safety and Tolerability of Vertebral Bone Marrow-derived Mesenchymal Stem Cells (BM-MSC) in Real World Scenarios of Patients With Chronic Kidney Disease (CKD)

Who this might be right for
Chronic Kidney DiseasesKidney Transplant
Mayo Clinic 75
Large-scale testing (Phase 3)Study completedNCT00808795
What this trial is testing

Efficacy of N-Acetylcysteine in Prevention of Post-Catheterization Contrast-Induced Nephropathy in Diabetic Patients With Chronic Kidney Disease

Who this might be right for
Radiocontrast-Induced NephropathyChronic Kidney DiseaseDiabetes Mellitus
Tehran University of Medical Sciences 90
Testing effectiveness (Phase 2)Study completedNCT01424319
What this trial is testing

Reducing Residual Albuminuria in Subjects With Diabetes and Nephropathy With Atrasentan

Who this might be right for
Chronic Kidney DiseaseDiabetic Nephropathy
AbbVie (prior sponsor, Abbott) 58
Testing effectiveness (Phase 2)WithdrawnNCT04661917
What this trial is testing

A Trial to Learn More About How BAY2327949 Works and How Safe it is in Patients Whose Kidneys Are Damaged Due to High Blood Sugar Levels or High Blood Pressures, and With a Further Disease of the Heart or the Blood Vessels.

Who this might be right for
Chronic Kidney DiseaseDiabetic Kidney Disease
Bayer
Large-scale testing (Phase 3)Ended earlyNCT04741074
What this trial is testing

Effect of Subcutaneous Semaglutide on Kidney Transplant Candidacy

Who this might be right for
CKDDiabetic Kidney DiseaseType 2 Diabetes Mellitus in Obese+2 more
Geisinger Clinic 15
Not applicableStudy completedNCT04903496
What this trial is testing

Clinical Characteristics and Disease Burden of Diabetic Patients Based on Tianjin Regional Database

Who this might be right for
Diabetes
Boehringer Ingelheim 1,233,162
Large-scale testing (Phase 3)Study completedNCT00800683
What this trial is testing

Safety and Efficacy in Type 2 Diabetic Patients With Severe Chronic Renal Impairment, 5 mg BI 1356 (Linagliptin) vs. Placebo, Insulin Background Inclusive

Who this might be right for
Diabetes Mellitus, Type 2
Boehringer Ingelheim 133
Large-scale testing (Phase 3)Study completedNCT00141453
What this trial is testing

ORIENT: Olmesartan Reducing Incidence of End Stage Renal Disease in Diabetic Nephropathy Trial

Who this might be right for
Diabetic NephropathyType 2 Diabetes MellitusProteinuria
Daiichi Sankyo Co., Ltd. 577
Testing effectiveness (Phase 2)UnknownNCT02312050
What this trial is testing

A Phase 2b Study of GCS-100 in Patients With Chronic Kidney Disease Caused by Diabetes

Who this might be right for
Diabetic Chronic Kidney Disease
La Jolla Pharmaceutical Company 375
Load More Results